This page lists all known medications that could potentially lead to 'Keratoconjunctivitis' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Please provide your email address to receive an email when new articles are posted on . CHESAPEAKE, Va. — Approximately 70% of patients with keratoconjunctivitis sicca have some amount of meibomian ...

Vernal keratoconjunctivitis (VKC) is a chronic, bilateral, allergic condition primarily affecting children and young adults. It is a seasonal allergic inflammatory disease of the eye with episodes of ...

Please provide your email address to receive an email when new articles are posted on . Steroid-induced glaucoma was more likely with at least 6 months of use, higher potency and urban residence.

Allergic eye diseases encompass a spectrum of ocular conditions resulting from hypersensitive immune reactions, with manifestations ranging from mild allergic conjunctivitis to more severe ...

The approval was based on data from two randomized, multicenter, double-masked, vehicle-controlled trials that evaluated the efficacy and safety of Verkazia in patients with VKC. The Food and Drug ...

Verkazia is an oil-in-water cationic emulsion that works by inhibiting T-cell activation and reducing the level of immune cells and mediators. Verkazia ® (cyclosporine ophthalmic emulsion) 0.1% is now ...

With the FDA's approval last week of cyclosporine ophthalmic emulsion 0.1% (Verkazia), ophthalmologists now have another option to treat their patients, both adults and children, with vernal ...

To investigate a cluster of microsporidial keratoconjunctivitis in 33 eyes of 25 previously healthy paediatric and teenage individuals after a rugby match. An observational case series was reported.

The global epidemic keratoconjunctivitis treatment market is anticipated to reach a market size of US$ 500 million in 2023 and US$ 814.45 million by exhibiting a CAGR of 5% from 2023 to 2033. From ...